Search results for "After treatment"

showing 10 items of 80 documents

Binucleate cells in the Ehrlich ascites tumor. Action of 5-fluorouracil.

1987

Time-dependent frequency distribution of binucleate cells (BC) was studied in Ehrlich ascites tumor (EAT) growing in mice. In animals that received no further treatment, the number of BC increased slowly from 2.6% to 16.5% of total cells within 8 days. In animals that were treated with different doses of 5-fluorouracil (FU) we found clearly higher numbers of BC. The number of BC increased with tumor age. The increase observed after treatment was reached more quickly in animals that had received the highest FU dose. The final number of BC was also dependent on the age of the tumor at the time of FU injection.

Cell NucleusDose-Response Relationship DrugCell BiologyGeneral MedicineBiologyPharmacologyEhrlich ascitesMiceFluorouracilImmunologymedicineMitotic IndexDistribution (pharmacology)AnimalsFemaleFluorouracilCarcinoma Ehrlich TumorAfter treatmentmedicine.drugBiology of the cell
researchProduct

Induction of micronucleated and binucleate cells in Chinese hamster ovary (CHO) cells by cis-diamminedichloroplatinum (II): a morphological and morph…

1990

Abstract The mutagenicity and cytotoxicity of cis -diamminedichloroplatinum (II) (cisplatin) at doses of 5, 10 and 20 μg/ml in Chinese hamster ovary (CHO) cells have been examined. A morphological characterization of several cell types induced by cisplatin was carried out. The frequencies of both cells with micronuclei and binucleate cells as a time-dependent parameter have also been studied. Whilst the number of cells with micronuclei was found to decrease with time, the number of binucleate cells increased. The possible kinetic mechanism for the production of binucleate cells and cells with micronuclei is discussed. A morphometric analysis was also performed. The nuclear area in both trea…

Cell NucleusGeneticsCisplatinCis diamminedichloroplatinum iiCell typeMicronucleus TestsDose-Response Relationship DrugChinese hamster ovary cellNuclear areaBiologyToxicologyMolecular biologyCricetinaeMicronucleus testGeneticsmedicineAnimalsCisplatinCytotoxicityInterphaseCell DivisionCells CulturedAfter treatmentmedicine.drugMutation Research/Genetic Toxicology
researchProduct

Binucleate cells in the Ehrlich ascites tumor. Autoradiographic labeling

1989

Abstract An autoradiographic study was performed on binucleate and mitotic cells in the Ehrlich ascites tumor (EAT) untreated and after treatment with 5-fluorouracil (FU). The number of binucleate cells was greater in the treated tumor than in the controls. It was also observed that the number of labeled mitoses was greater in the Fu-treated tumor. Autoradiographic labeling showed that the cells that proved to be binucleate had previously passed through S-phase; thus, these cells belonged to the proliferative compartment.

Cell NucleusPathologymedicine.medical_specialtyBinucleated cellsMice Inbred StrainsCell BiologyGeneral MedicineCompartment (chemistry)BiologyTritiumEhrlich ascitesMiceBiochemistryMitotic IndexmedicineAnimalsAutoradiographyFemaleFluorouracilCarcinoma Ehrlich TumorMitosisAfter treatmentThymidineBiology of the Cell
researchProduct

Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI

2018

OBJECTIVE. Benign hepatic lesions may occur after chemotherapy treatment and may mimic metastases at imaging. We describe focal nodular hyperplasia (FNH) lesions diagnosed at MRI that occurred de n...

Chemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentFocal nodular hyperplasiaGeneral Medicinemedicine.disease030218 nuclear medicine & medical imagingOxaliplatinGadoxetate Disodium03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesismedicineRadiology Nuclear Medicine and imagingRadiologybusinessAfter treatmentmedicine.drugAmerican Journal of Roentgenology
researchProduct

Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.

2002

Metabolically formed dihydrodiol epoxides in the bay-region of polycyclic aromatic hydrocarbons are thought to be responsible for the genotoxic properties of these environmental pollutants. The hexacyclic aromatic hydrocarbon dibenzo[def,mno]chrysene (anthanthrene), although lacking this structural feature, was found to exhibit considerable bacterial mutagenicity in histidine-dependent strains TA97, TA98, TA100, and TA104 of S. typhimurium in the range of 18-40 his(+)-revertant colonies/nmol after metabolic activation with the hepatic postmitochondrial fraction of Sprague-Dawley rats treated with Aroclor 1254. This mutagenic effect amounted to 44-84% of the values determined with benzo[a]py…

ChryseneMaleSalmonella typhimuriumStereochemistryAnthanthreneToxicologyRats Sprague-Dawleychemistry.chemical_compoundmedicineAnimalsBenzopyreneschemistry.chemical_classificationStrain (chemistry)Mutagenicity TestsGeneral MedicineChlorodiphenyl (54% Chlorine)RatschemistryEnzyme InductionPhenobarbitalMicrosomeMicrosomes LiverPyrenePhenobarbitalAromatic hydrocarbonAfter treatmentNADPmedicine.drugMethylcholanthreneMutagensChemical research in toxicology
researchProduct

Virtual reality in the treatment of claustrophobic fear: A controlled, multiple-baseline design

2000

The aim of this study was to determine the effectiveness of virtual reality (VR) exposure in the treatment of claustrophobic fear. We evaluated the intervention following a controlled, multiple-baseline design across 4 participants with claustrophobic fear who sought psychological help in our anxiety disorders clinic. The treatment consisted of 8 individual VR graded exposure sessions. Data were obtained at pretreatment, posttreatment, and 3-month follow-up on several clinical measures: Behavioral Avoidance Test, Self-Efficacy Toward Closed Spaces, Problem-Related Impairment Questionnaire, Beck Depression Inventory (Beck, 1978), and Anxiety Sensitivity Index (Peterson & Reiss, 1992). Result…

Clinical PsychologyMultiple baseline designPsychotherapistIntervention (counseling)Beck Depression InventoryAnxiety sensitivitymedicineAnxietyBehavioral avoidancemedicine.symptomVirtual realityPsychologyAfter treatment
researchProduct

ESR Spectra o f Normal Human Serum after Treatment with Complement Activating Agents*

1980

Abstract We describe the appearance of a free-radical signal in the ESR spectrum of normal human serum incubated with several complement activating agents. The intensity of this signal is dependent of dose of activating agents, time and temperature. Signals elicited by different complement activators differ in morphology and kinetics. Inhibition by treatment with EDTA and the presence of the signal in activated C 6-deficient rabbit serum suggest that the con-vertase forming steps of complement activation (C2 to 5) could be the source of free-radical containing molecules.

Elapid VenomsMaleFree RadicalsChemistryKineticsElectron Spin Resonance SpectroscopyZymosanBlood ProteinsComplement System ProteinsGeneral Biochemistry Genetics and Molecular BiologyComplement systemComplement (complexity)Esr spectraBiochemistryHumansFemaleComplement ActivationAfter treatmentZeitschrift für Naturforschung C
researchProduct

Pharmakologisch-aktive polymere, 18. Körperverteilung und ausscheidungsverhalten von monomerem und polymerem sulfadiazinacrylamid

1979

Sulfadiazinacrylamid was absorbed after oral and intraperitoneal application in rats to a high extent; the absorption from the intraperitoneum was retarded. Glucose treatment delayed the absorption after both application forms. At comparatively high renal and enteral excretion rates the biological half life time of the monomer was estimated to 8 h. A tumouraffinity was not found but there were indications for a preferred storage in the RES. Poly[sulfadiazinacrylamide] was absorbed after intraperitoneal injection to a clear extent, where at the beginning of the treatment under simultaneous glucose load the absorption was delayed. 24 h after injection higher concentrations in metabolic organs…

Excretionchemistry.chemical_compoundMonomerchemistrymedicine.medical_treatmentPolymer chemistryIntraperitoneal injectionmedicineBiological half-lifeAbsorption (skin)Enteral administrationAfter treatmentResorptionDie Makromolekulare Chemie
researchProduct

Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging

2021

Abstract Objectives The 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid–enhanced imaging. Methods As at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid–enhanced MRI in primary l…

Gadolinium DTPAMagnetic Resonance SpectroscopyHepatocellular carcinomaGadoxetic acidContrast MediaOral and gastrointestinal030218 nuclear medicine & medical imagingLiver disease0302 clinical medicineCancerNeuroradiologymedicine.diagnostic_testLiver DiseaseLiver NeoplasmsInterventional radiologyGeneral MedicineMetastatic liver diseaseNuclear Medicine & Medical Imaging030220 oncology & carcinogenesisBiomedical ImagingRadiologymedicine.symptomPrimary liver cancerAfter treatmentmedicine.drugLiver Cancermedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularConsensusChronic Liver Disease and CirrhosisClinical SciencesSensitivity and Specificity03 medical and health sciencesMagnetic resonance imagingRare DiseasesmedicineHumansRadiology Nuclear Medicine and imagingRetrospective Studiesbusiness.industryCarcinomaHepatocellularMetastatic liver diseaseMagnetic resonance imagingmedicine.diseaseOrphan DrugDigestive DiseasesbusinessEuropean Radiology
researchProduct

2021

OBJECTIVE To investigate long-term health-related quality of life (HRQoL) changes over time in younger compared to older disease-free breast cancer survivors who participated in a prospective randomized exercise trial. METHODS Survivors (aged 35-68 years) were randomized to a 12-month exercise trial after adjuvant treatment and followed up for ten years. HRQoL was assessed with the generic 15D instrument during follow-up and the younger (baseline age ≤ 50) and older (age >50) survivors' HRQoL was compared to that of the age-matched general female population (n = 892). The analysis included 342 survivors. RESULTS The decline of HRQoL compared to the population was steeper and recovery slower…

Health related quality of lifeeducation.field_of_studyPopulation levelbusiness.industryPopulationGeneral Medicinemedicine.diseasehumanities3. Good healthMenopause03 medical and health sciences0302 clinical medicineBreast cancerQuality of life030220 oncology & carcinogenesismedicineSurgery030212 general & internal medicineeducationbusinessAfter treatmentFemale populationDemographyThe Breast
researchProduct